Standout Papers

Establishment and characterization of a human prostatic carcinoma cell line (PC-3). 1979 2026 1994 2010 1.4k
  1. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). (1979)
    Kaighn Me, Yuko Ohnuki et al. PubMed

Citation Impact

Citing Papers

Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
2004
Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells
2004
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Chromosomal Evolution in Cell Populations
1962
Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
2001
Identifying positive selection candidate loci for high-altitude adaptation in Andean populations
2009
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Effects of an Rb mutation in the mouse
1992 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines
2010
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
2005 StandoutNature
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Cancer Metastasis: Building a Framework
2006 Standout
Structure and physical map of 64 variable segments in the 3′ 0.8–megabase region of the human immunoglobulin heavy–chain locus
1993 StandoutNobel
Renal-Cell Carcinoma
1996 Standout
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
1992 StandoutNobel
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
2011 StandoutNature
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Epigenetics in Cancer
2008 Standout
The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein
1991 StandoutNobel
Physical map of the human immunoglobulin K locus and its implications for the mechanisms of VK–JKrearrangement
1987
A new human prostate carcinoma cell line, 22Rv1
1999
Characterization of human prostate and breast cancer cell lines for experimental T cell‐based immunotherapy
2007
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
1994 StandoutNature
Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product
1991 StandoutNobel
Identification of a cold receptor reveals a general role for TRP channels in thermosensation
2002 StandoutNatureNobel
A TRP Channel that Senses Cold Stimuli and Menthol
2002 StandoutNobel
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Chapter 5 Laser Scissors and Tweezers
1997
The role of senescent cells in ageing
2014 StandoutNature
Geroscience: Linking Aging to Chronic Disease
2014 Standout
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
Mechanisms of Bone Metastasis
2004 Standout
The art and design of genetic screens: mammalian culture cells
2004
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 StandoutNature
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor
1997
Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study
2003
The Polycomb complex PRC2 and its mark in life
2011 StandoutNature
The cancer genome
2009 StandoutNature
Osteoblasts in prostate cancer metastasis to bone
2005
Reduction of the calcium requirement of normal human epithelial cells by EGF
1979
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
1987 Standout
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
1992 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
2001
Infrequent Involvement of P53 Mutations and Loss of Heterozygosity of 17p in the Tumorigenesis of Renal Cell Carcinoma
1993
Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line.
1982 StandoutNobel
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
Growth factor involvement in progression of prostate cancer.
1998
Homocamptothecins:  Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
1998
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
1999
Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
2002
The Clonal Evolution of Tumor Cell Populations
1976 StandoutScience
Chromosome instability in cell lineages of amniocyte clones morphologically transformed by Simian virus 40
1987
Aryl−Aryl Bond Formation by Transition-Metal-Catalyzed Direct Arylation
2007 Standout
Characteristics of established myeloma and lymphoblastoid cell lines derived from an e myeloma patient: A comparative study
1971
A revolution in optical manipulation
2003 StandoutNature
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV
1971
Molecular cloning and nucleotide sequencing of human immunoglobulin € chain cDNA
1983 StandoutNobel
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
1993
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Transforming activity of human tumor DNAs.
1981
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
1994
Activation of a translocated c-myc gene: role of structural alterations in the upstream region.
1984 StandoutNobel
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
1988 Standout
Application of the principles of enzyme kinetics to clonal growth rate assays: An approach for delineating interactions among growth promoting agents
1979
Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.
1986
In Vitro Selection of Functional Nucleic Acids
1999 StandoutNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Cytogenetic instability with balanced chromosome changes in an SV40 transformed human uroepithelial cell line.
1988
Expression of human immunoglobulin E ε chain cDNA inE.coli
1983 StandoutNobel
Neural Computing in Cancer Drug Development: Predicting Mechanism of Action
1992 StandoutScienceNobel
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
2008 Standout
Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the Nasopharynx
1974 StandoutNobel
Epidermal Growth Factor
1979 StandoutNobel
A strategy to discover circulating angiogenesis inhibitors generated by human tumors.
1995
Transforming Growth Factor-β: Biological Function and Chemical Structure
1986 StandoutScience
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
1991
In vitro transformation of human epithelial cells
1986
Detection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer
1997
Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations
1981
Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
1990 Science
Two routes to functional adaptation: Tibetan and Andean high-altitude natives
2007
Individual-specific ‘fingerprints’ of human DNA
1985 StandoutNature

Works of Yuko Ohnuki being referenced

Modification of nucleolar expression following laser micro-irradiation of chromosomes
1970
Genetic variation in hypoxia-inducible factor 1α and its possible association with high altitude adaptation in Sherpas
2003
Differential properties among clones of simian virus 40-transformed human epithelial cells
1980
Chromosomal instability of SV40-transformed human prostatic epithelial cell lines
1982
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
1979 Standout
Replicative Epithelial Cell Cultures From Normal Human Prostate Gland: Brief Communication2
1978
Chromosomal analysis of human prostatic adenocarcinoma cell lines.
1980
Multiple Myeloma—An In Vitro Study
1961
The development of a near-diploid in vitro strain from a smoke-condensate induced mouse tumor.
1960
Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma
1978
Rankless by CCL
2026